Intermediaries and Development of Biopharmaceuticals: Evidence From the Innovation Policy in a Developing Country
Strengthening intermediaries and implementing targeted policies based on companies' real needs can enhance the effectiveness of innovation policies, reduce import dependence, and improve the global competitiveness of Iran's biopharmaceutical industry.
Authors
- Atiyeh Safardoust (ORCID: https://orcid.org/0000-0003-0358-3451)
- Fereidoun Mahboudi (ORCID: https://orcid.org/0000-0002-3380-5257)
- Mohsen Pourqasem
- Soode Mirmohammadi
Institutions
- Pasteur Institute of Iran (IR)
- University of Tehran (IR)
- Iran National Science Foundation (IR)
Publication Details
- Journal
- The International Journal of Health Planning and Management
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1002/hpm.70034
- Primary Topic
- Biotechnology and Related Fields
- Type
- article
- Field-Weighted Citation Impact
- 0.00